Deprecated: Use of MediaWiki\Output\OutputPage::setIndexPolicy with index after noindex was deprecated in MediaWiki 1.43. [Called from MediaWiki\Output\OutputPage::setRobotPolicy in /home/forge/wikitrademarks.org/includes/Output/OutputPage.php at line 1008] in /home/forge/wikitrademarks.org/includes/debug/MWDebug.php on line 385
Category:Susan M. FREIER of San Diego CA (US) - WikiTrademarks Jump to content

Category:Susan M. FREIER of San Diego CA (US)

From WikiTrademarks
Revision as of 05:33, 31 March 2025 by Unknown user (talk) (Updating Category:Susan_M._FREIER_of_San_Diego_CA_(US))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Susan M. FREIER of San Diego CA (US)

Executive Summary

Susan M. FREIER of San Diego CA (US) is an inventor who has filed 1 patents. Their primary areas of innovation include Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants (1 patents), SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS (1 patents), MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media (1 patents), and they have worked with companies such as IONIS PHARMACEUTICALS, INC. (1 patents). Their most frequent collaborators include .

Patent Filing Activity

File:Susan M. FREIER of San Diego CA (US) Monthly Patent Applications.png

Technology Areas

File:Susan M. FREIER of San Diego CA (US) Top Technology Areas.png

List of Technology Areas

  • C12N15/113 (Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; {Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing (when used in plants): 1 patents
  • A61P13/02 (SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS): 1 patents
  • C12N2310/11 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2310/315 (of the backbone): 1 patents
  • C12N2310/321 (2'-O-R Modification): 1 patents
  • C12N2310/3231 (modified ring structure): 1 patents
  • C12N2310/3341 (of the base): 1 patents
  • C12N2310/341 (Spatial arrangement of the modifications): 1 patents
  • C12N2310/346 (Spatial arrangement of the modifications): 1 patents
  • C12N2320/32 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents
  • C12N2320/35 (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media): 1 patents

Companies

File:Susan M. FREIER of San Diego CA (US) Top Companies.png

List of Companies

  • IONIS PHARMACEUTICALS, INC.: 1 patents

Collaborators

Subcategories

This category has only the following subcategory.

Cookies help us deliver our services. By using our services, you agree to our use of cookies.